Cue Biopharma director files initial Form 3

Cue Biopharma, Inc. filed an initial ownership report for director Meehan Viola Mong on Form 3.

Rhea-AI Filing Summary

Cue Biopharma, Inc. filed an initial ownership report for director Meehan Viola Mong on Form 3. The filing identifies Mong as a director and not a ten percent owner, and shows no reported transactions or holdings in the summarized data.

Key Terms

Form 3, reporting person, director, ten percent owner

4 terms

Form 3 regulatory

"INSIDER FILING DATA (Form 3)"

Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.

reporting person regulatory

""reportingPersons": [ { "name": "Meehan Viola Mong""

director regulatory

""is_director": 1"

ten percent owner regulatory

""is_ten_percent_owner": 0"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Cue Biopharma (CUE) Form 3 filing report for Meehan Viola Mong?

The Form 3 for Cue Biopharma reports that Meehan Viola Mong is a director and not a ten percent owner. It is an initial ownership statement and, in this summarized data, shows no reported transactions or holdings for the reporting person.

Does the Cue Biopharma (CUE) Form 3 show any share purchases or sales by Meehan Viola Mong?

The summarized Form 3 data for Cue Biopharma shows no share purchases or sales by Meehan Viola Mong. All transaction counts and share amounts in the transaction summary are zero, indicating no reported trading activity in this filing excerpt.

Is Meehan Viola Mong a ten percent owner of Cue Biopharma (CUE) according to the Form 3?

According to the Form 3 data, Meehan Viola Mong is not a ten percent owner of Cue Biopharma. The filing flags her as a director, while the ten percent owner indicator is set to zero, meaning that threshold is not met in this report.

What types of insider activity are summarized in the Cue Biopharma (CUE) Form 3 transaction summary?

The transaction summary covers buys, sells, derivative exercises, gifts, tax withholding, and restructuring-related transfers. In this Cue Biopharma Form 3, every category shows a count of zero and zero shares, indicating no such activities are reported in this snapshot.

Does the Cue Biopharma (CUE) Form 3 include any derivative positions for Meehan Viola Mong?

The provided Form 3 data shows an empty derivative summary for Meehan Viola Mong. That means no options, warrants, or other derivative securities are listed in this excerpt as being held or affected in connection with the initial ownership reporting.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/02/2026 - 08:41 PM EDT Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Meehan Viola Mong

(Last) (First) (Middle)

C/O CUE BIOPHARMA, INC.

40 GUEST STREET

(Street)

BOSTON MASSACHUSETTS 02135

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
05/30/2026

3. Issuer Name and Ticker or Trading Symbol
Cue Biopharma, Inc. [ CUE ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

No securities are beneficially owned.

	/s/ Michael Meluzio, Attorney-in-Fact	06/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)